TP53 and hepatocellular carcinoma: It was also found that the TP53 mutation rate in the high-risk group was significantly higher than those in the low-risk group, and TP53 249Ser mutation may be a high-risk factor of HBV-related HCC recurrence in the short term [47, 48].